Seven Bridge Financial Group, LLC Crispr Therapeutics Ag Transaction History
Seven Bridge Financial Group, LLC
- $465 Million
- Q2 2024
A detailed history of Seven Bridge Financial Group, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Seven Bridge Financial Group, LLC holds 5,651 shares of CRSP stock, worth $270,852. This represents 0.07% of its overall portfolio holdings.
Number of Shares
5,651
Previous 5,651
-0.0%
Holding current value
$270,852
Previous $385,000
20.78%
% of portfolio
0.07%
Previous 0.09%
Shares
10 transactions
Others Institutions Holding CRSP
# of Institutions
510Shares Held
57.7MCall Options Held
1.74MPut Options Held
1.84M-
Capital International Investors Los Angeles, CA7.87MShares$377 Million0.09% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$359 Million3.35% of portfolio
-
Nikko Asset Management Americas, Inc.3.15MShares$151 Million1.99% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.15MShares$151 Million0.13% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$133 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.74B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....